Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up
نویسندگان
چکیده
منابع مشابه
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
This paper demonstrates multiple benefits of intravitreal bevacizumab (IVB) on diabetic retinopathy (DR) including diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) at 24 months of followup. This is a retrospective multicenter interventional comparative case series of intravitreal injections of 1.25 or 2.5 mg of bevacizumab for DME, PDR without tractional retinal detachm...
متن کاملIntravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
PURPOSE To evaluate the efficacy of intravitreal injection of bevacizumab (Avastin) (IVA) in preventing panretinal photocoagulation (PRP)-induced macular thickening and visual dysfunction in eyes with severe proliferative diabetic retinopathy. METHODS A retrospective review of 60 consecutive eyes (30 patients) with severe proliferative diabetic retinopathy whose visual acuity was 20/30 or bet...
متن کاملIntravitreal Bevacizumab in the Surgical Treatment of Proliferative Diabetic Retinopathy
T R E ATM E N T O F PD R In 2005, after our initial encouraging experience with intravitreal bevacizumab for age-related macular degeneration, I began to use it in patients with rubeosis. The first patient I treated presented with bilateral neovascularization, rubeosis in the right eye, and partial vitreous hemorrhage in the left eye.1 I applied panretinal photocoagulation (PRP) for the left ey...
متن کاملIntravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study): 1-year results.
PURPOSE To evaluate the effect of intravitreal bevacizumab on area of fluorescein leakage from active new vessels (NVs) and on best-corrected visual acuity in patients with actively leaking NV associated with diabetic retinopathy unresponsive to panretinal photocoagulation. METHODS A prospective open-label study of diabetic patients with actively leaking NV refractory to panretinal photocoagu...
متن کاملIntravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
OBJECTIVE Intravitreal Bevacizumab (Avastin, Genentech Inc., San Francisco, CA) (IVB) has been shown to cause regression of neovessels in proliferative diabetic retinopathy due to its anti-angiogenic effects. This study was performed to investigate the role of Avastin as an adjunct to the management of patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy. METHODOL...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Eye
سال: 2007
ISSN: 0950-222X,1476-5454
DOI: 10.1038/sj.eye.6702980